PetMed Express director forfeits 26,057 shares
PetMed Express director Gian Fulgoni reported an automatic forfeiture of 26,057 shares of common stock on January 21, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PetMed Express director Gian Fulgoni reported an automatic forfeiture of 26,057 shares of common stock on January 21, 2026. The Form 4 shows this as a disposition at a price of $0.00 per share, reflecting that the shares were forfeited rather than sold for cash.
According to the footnote, the forfeiture was required under the applicable award agreement for restricted shares that had been granted on October 30, 2025, and occurred due to the termination of his director service as of January 21, 2026. After this change, Fulgoni directly beneficially owns 132,299 shares of PetMed Express common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Common Stock | 26,057 | $0.00 | $0.00 |
Footnotes (1)
- F1. This Form 4 is being filed to reflect the automatic forfeiture, in accordance with the applicable award agreement, of a portion of the restricted shares granted on October 30, 2025 to the reporting person due to the termination of director service by the reporting person as of January 21, 2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did PETS director Gian Fulgoni report?
Director Gian Fulgoni reported an automatic forfeiture of 26,057 shares of PetMed Express common stock on January 21, 2026, recorded as a disposition at $0.00 per share.
Did the PetMed Express director receive any cash from this Form 4 transaction?
No. The transaction is reported at a price of $0.00 per share, indicating an automatic forfeiture of restricted shares rather than a sale for cash.
Is this PetMed Express Form 4 transaction a sale on the open market?
No. The Form 4 describes the event as an automatic forfeiture of restricted shares at $0.00 per share, not as an open-market sale.
AI-generated analysis. How Rhea-AI works. Not financial advice.